0001127602-22-001454.txt : 20220113
0001127602-22-001454.hdr.sgml : 20220113
20220113163814
ACCESSION NUMBER: 0001127602-22-001454
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211214
FILED AS OF DATE: 20220113
DATE AS OF CHANGE: 20220113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gayer Charles K
CENTRAL INDEX KEY: 0001800110
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 22529436
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BLVD.
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4/A
1
form4a.xml
PRIMARY DOCUMENT
X0306
4/A
2021-12-14
2021-12-16
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001800110
Gayer Charles K
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Chief Commercial Officer
Common Stock
2021-12-14
4
A
0
80000
0
A
216556
D
The number of restricted stock units awarded to the reporting person on December 14, 2021 was overstated in the original Form 4 due to an administrative error. This amendment corrects the error and reflects the corrected amount of restricted stock units awarded to the reporting person on such date.
/s/ Alane P. Barnes, by power of attorney
2022-01-13